Search
for
Sort by
Research 211–240 of 521
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- The JAK/STAT signaling pathway: from bench to clinic
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Immune therapies for alopecia areata: evidence and new perspectives
- New Modalities in the Treatment of Refractory Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Skin Pigmentation Types, Causes and Treatment—A Review
- Alopecia Areata: An Updated Review for 2023
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Alopecia Areata: Current Treatments and New Directions
- Resident Memory T Cells in Autoimmune Skin Diseases
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology